Cardiovascular Risk ScoreNCT05330962
10 Years Cardiovascular Risk Score Among Primary Health Care Centre Attendees, Assiut Governorate.
An observational study of Cardiovascular Risk Score, run by Assiut University.
Trial summary
The study aim to assess cardiovascular risk score among patients of AlHadary primary health care centre in Waldeya, Assiut governorate. And to determine the awareness about cardiovascular risk among these patients as well. Read more about this study
- Who is it for?
- Ages 30 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Cardiovascular Risk Score
- What is being tested?
- Framingham study cardiovascular disease 10-years risk assessment score
- How many people
- 383 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2022to 1 Jun 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Attendees of primary health care centre, Assiut governorate.
Who may be able to join
- Male 30-65 years old, or female 40-70 years old.
Who cannot join
- History of ischemic heart disease, stroke, transitory ischemic attack (TIA) or peripheral artery disease (PAD) in electronic health record.
- History of diabetes
Trial locations and contacts
No sites are listed yet.
About this study
The study aim to assess cardiovascular risk score among patients of AlHadary primary health care centre in Waldeya, Assiut governorate. And to determine the awareness about cardiovascular risk among these patients as well.
Read the detailed description
An analytical, cross-sectional study will be conducted in a primary health care center in Assiut governorate. Aiming to assess cardiovascular risk among attendees of the center and determine the awareness about cardiovascular risk among them.
- Conditions
- Cardiovascular Risk Score
- Being tested
- Framingham study cardiovascular disease 10-years risk assessment score
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Framingham study cardiovascular disease 10-years risk assessment scoreOther
Also called ASCVD risk estimator
A personal interview questionnaire
What is being measured
The primary outcome is the main question the study is designed to answer.
The Framingham study cardiovascular disease 10 years risk assessment results
Participants will be categorized into four risk groups based on the 10 years ASCVD risk percentages.
Measured: 1 year
Secondary outcomes (1)
Total cardiovascular disease knowledge score results
will be calculated by summing the scores of respondents concerning cardiovascular disease types, heart attack symptoms, stroke symptoms and CVR factors. Total knowledge score will be 24. knowledge levels will be categorized as low knowledge, moderate knowledge and high knowledge.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Apr 2022
- Study start1 Nov 2022 (estimated)
- Primary completion1 May 2023 (estimated)
- Study completion1 Jun 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cardiovascular Risk ScoreStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 383 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Asma Ahmed Rafat Najeeb, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05330962
- Sponsor's protocol ID
- Cardiovascular risk score
- Status last verified
- Aug 2022
- First submitted
- 10 Apr 2022
- Last updated
- 10 Aug 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Yacoub M, Mayosi B, ElGuindy A, Carpentier A, Yusuf S. Eliminating acute rheumatic fever and rheumatic heart disease. Lancet. 2017 Jul 15;390(10091):212-213. doi: 10.1016/S0140-6736(17)31608-2. No abstract available.
PubMed 28721865
Study at a glance
From the registry record, last updated by the sponsor on 10 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- 10 Years Cardiovascular Risk Score Among Primary Health Care Centre Attendees, Assiut Governorate.
- ClinicalTrials.gov ID
- NCT05330962
- Acronym / sponsor ID
- Cardiovascular risk score
- Conditions
- Cardiovascular Risk Score
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 383 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Nov 2022 (estimated)
- Primary completion
- 1 May 2023 (estimated)
- Study completion
- 1 Jun 2023 (estimated)
- First posted
- 15 Apr 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study aim to assess cardiovascular risk score among patients of AlHadary primary health care centre in Waldeya, Assiut governorate. And to determine the awareness about cardiovascular risk among these patients as well.
Detailed description
An analytical, cross-sectional study will be conducted in a primary health care center in Assiut governorate. Aiming to assess cardiovascular risk among attendees of the center and determine the awareness about cardiovascular risk among them.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 30 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Attendees of primary health care centre, Assiut governorate.
Key inclusion criteria (1 listed)
- Male 30-65 years old, or female 40-70 years old.
Key exclusion criteria (2 listed)
- History of ischemic heart disease, stroke, transitory ischemic attack (TIA) or peripheral artery disease (PAD) in electronic health record.
- History of diabetes
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Framingham study cardiovascular disease 10-years risk assessment scoreAlso: ASCVD risk estimatorA personal interview questionnaire | Other | – |
Primary outcome
The Framingham study cardiovascular disease 10 years risk assessment results
Time frame: 1 year
Participants will be categorized into four risk groups based on the 10 years ASCVD risk percentages.
1 secondary outcome
Total cardiovascular disease knowledge score results
Time frame: 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Aug 2022.
- Results publication: PubMed 28721865Yacoub M, Mayosi B, ElGuindy A, Carpentier A, Yusuf S. Eliminating acute rheumatic fever and rheumatic heart disease. Lancet. 2017 Jul 15;390(10091):212-213. doi: 10.1016/S0140-6736(17)31608-2. No abstract available.
- Importance of Lifestyle Modification on Cardiovascular Risk Reduction COUNSELING STRATEGIES TO MAXIMIZE PATIENT OUTCOMESLink provided by the sponsor.
- Cardiovascular Risk Awareness and Calculated 10-Year Risk Among Female Employees at Taibah University 2019Link provided by the sponsor.
- Individual participant dataSharing planned: Undecided
Related trials for Cardiovascular Risk Score
Not yet recruitingObservational study
Assessment of Transnational Performance of the Universal Cardiac Surgical Risk Score Across International Sites
Heart Valve Diseases, Cardiac Surgical Procedures
Recruiting
Pharmacogenomic Informed Statin Prescribing
Hypercholesterolemia
Not yet recruiting
Neqpiaput Iinruugut (Our Food Is Medicine): A Tribally Driven Food Sovereignty Intervention to Reduce Heart Disease Risk in Alaska Native Adults
Cardiovascular (CV) Risk
RecruitingObservational study
Aortic Dissection Detection Risk Score With D-dimer to Rule-Out Acute Aortic Syndrome
Acute Aortic Syndrome
RecruitingObservational study
Prevalence and Associated Factors of High BMI and Periodontitis in Thai Adults Aged Under 60 Years
Diabete Mellitus, Dyslipidaemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiovascular Risk Score, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 10 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Asma A Rafat (+201030533071, asmaacc@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The Framingham study cardiovascular disease 10 years risk assessment results (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05330962, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2022.